NEW YORK, April 27, 2006 (PRIMEZONE) -- Seeger Weiss LLP announces that it is investigating claims against Bausch & Lomb, Inc. (NYSE:BOL) for eye-related injuries, including reports of varying degrees of blindness. ReNu with MoistureLoc, a popular product of Bausch & Lomb, Inc., is used for daily cleaning and disinfection of contact lenses. Recently, Bausch & Lomb, Inc. halted shipments and asked retailers in the United States to remove ReNu with MoistureLoc from shelves after the product was linked to reports of Fusarium keratitis. According to the FDA, as of April 9, 109 cases of suspected Fusarium keratitis were under investigation in 17 states. The Associated Press has reported that the number of cases has now grown to 176 in 28 states. Fusarium keratitis is a fungal eye infection that can scar the cornea and lead to blindness if it is not properly treated or if the individual does not respond to antifungal medications. Users of ReNu with MoistureLoc are advised by the FDA to cease using it immediately and to discard any remaining solution. If you or a loved one has used ReNu with MoistureLoc and experienced any of the aforementioned side-effects, please visit http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/ReNu-with -MoistureLoc-P126/ or call (877) 541-3273 to request a free evaluation.
About Seeger Weiss LLP
Seeger Weiss (http://www.seegerweiss.com/) is a New York based law firm that is active in major complex litigations, including pharmaceutical mass tort and product defect cases pending in federal and state courts throughout the United States. Seeger Weiss has taken a leading role in many important actions on behalf of injured consumers and has successfully recovered millions of dollars for individual clients and class members. For example, Seeger Weiss currently serves as Court Appointed Co-Lead Counsel in the federal Vioxx Litigation (http://www.seegerweiss.com/cases/Cases.aspx?ID=24) and was one of the lead firms that negotiated the recently announced $700 million settlement of claims on behalf of individuals who were injured as a result of their use of the prescription drug Zyprexa (http://www.seegerweiss.com/cases/Cases.aspx?ID=27).
If you or a family member is using or has used ReNu with MoistureLoc and would like to discuss your rights, or if you have information concerning the potential adverse consequences associated with the use of this product that you would like to share with us, please contact us:
Christopher A. Seeger, Esq. http://www.lawyerseek.com/Attorneys/Christopher-A-Seeger-Partners -E3.html David R. Buchanan, Esq. http://www.lawyerseek.com/Attorneys/David-R-Buchanan-Partners-E6.html Seeger Weiss LLP One William Street New York, New York 10004 E-Mail: cseeger@seegerweiss.com dbuchanan@seegerweiss.com Tel: (212) 584-0700 Toll Free: (877) 541-3273 http://www.seegerweiss.com, http://www.lawyerseek.com
To submit a claim for review please visit: http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/ReNu-with-MoistureLoc-P126/.